Results 131 to 140 of about 61,515 (260)

Evaluating alignment of UK commercial baby food products with the WHO nutrient and promotion profile model. [PDF]

Eur J Pediatr
Bozkir C, Esin K, Threapleton D, Cade JE.   +3 more
europepmc   +1 more source

Examining the Environmental Impacts of the Dairy and Baby Food Industries: Are First-Food Systems a Crucial Missing Part of the Healthy and Sustainable Food Systems Agenda Now Underway? [PDF]

Int J Environ Res Public Health, 2021
Pope DH, Karlsson JO, Baker P, McCoy D.
europepmc   +1 more source

Evaluating the (comparative) safety profile of the novel oral polio vaccine type 2 using individual case safety reports in VigiBase

British Journal of Clinical Pharmacology, EarlyView.
Aim Novel oral polio vaccine type 2 (nOPV2) was used under the WHO emergency use listing for circulating vaccine‐derived polio virus (cVDPV) outbreaks from 2021 to 2023. We assessed nOPV2 adverse events following immunization (AEFIs) and compared its safety profile to other vaccines using VigiBase.
Comfort Kunak Ogar, Malede Mequanent Sisay, Leonardo Roque‐Pereira, Christine Leopold, Patrick C. Souverein, Aukje K. Mantel‐Teeuwisse, Marie L. De Bruin   +6 more
wiley   +1 more source

Chemical characterization of baby food consumed in Italy. [PDF]

PLoS One
Meli MA, Desideri D, Sisti D, Fagiolino I, Roselli C.   +4 more
europepmc   +1 more source

Globalization, first-foods systems transformations and corporate power: a synthesis of literature and data on the market and political practices of the transnational baby food industry. [PDF]

Global Health, 2021
Baker P, Russ K, Kang M, Santos TM, Neves PAR, Smith J, Kingston G, Mialon M, Lawrence M, Wood B, Moodie R, Clark D, Sievert K, Boatwright M, McCoy D.   +14 more
europepmc   +1 more source

PrEP at the site of action in cisgender and transgender women: A pharmacology study of blood and rectal CD4+ lymphocytes

British Journal of Clinical Pharmacology, EarlyView.
Background Female sex hormones used in feminizing hormone therapy (FHT) may influence activation and persistence of HIV pre‐exposure prophylaxis (PrEP) medications. The clinical relevance of this interaction remains unclear, particularly for transgender and cisgender women (TGW and CGW).
Elizabeth Hastie, Megha Srivasta, Edward R. Cachay, Leah Burke, Sara Gianella, Stephen Rawlings, Frank Z. Stanczyk, Craig Sykes, Angela D. M. Kashuba, Jill Blumenthal, Mackenzie L. Cottrell   +10 more
wiley   +1 more source

Colorimetric enzymatic rapid test for the determination of atropine in baby food using a smartphone. [PDF]

Anal Bioanal Chem
Domínguez M, Moraru D, Lasso S, Sanz-Vicente I, de Marcos S, Galbán J.   +5 more
europepmc   +1 more source

Fish-Based Baby Food Concern-From Species Authentication to Exposure Risk Assessment. [PDF]

Molecules, 2020
Pappalardo AM, Copat C, Raffa A, Rossitto L, Grasso A, Fiore M, Ferrante M, Ferrito V.   +7 more
europepmc   +1 more source

Effects of storage temperature and packaging material on physico-chemical, microbial and sensory properties and shelf life of extruded composite baby food flour. [PDF]

Heliyon, 2021
Forsido SF, Welelaw E, Belachew T, Hensel O.   +3 more
europepmc   +1 more source

Optimal dosing for vascular anomalies paediatric patients with population pharmacokinetic model of sirolimus

British Journal of Clinical Pharmacology, EarlyView.
Abstract Aim Sirolimus is currently used off‐label for paediatric patients with vascular anomalies. However, the optimal dosage regimen for paediatric patients remains controversial. This study aimed to determine the optimal dosing regimen of sirolimus in these patients using a population pharmacokinetic (PK) model.
Seongmee Jeong, Jungryul Kim, Woojin Jung, Jiyeon Jeon, Hyeongjun Jo, Kyoung‐Bin Ryu, Ja‐Young Hong, Kwan Soo Kim, Seongjun Yang, Hee Young Ju, Hwi‐yeol Yun, Jung‐woo Chae, Keon Hee Yoo, Soyoung Lee   +13 more
wiley   +1 more source